insights_auto
Why is BOT up 22.22%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.011
arrow_upward
+22.22%(+0.0020) 1D
Nov 5, 4:10:30 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
30.39M
Avg. vol.
9.08M
Volume
7.72M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
30.39M
Avg. vol.
9.08M
Volume
7.72M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
Serrari Group
·
1 hour ago
Dow Surges 1,569 Points as Election Reshapes Wall Street
TradingView
·
2 hours ago
DJI: Dow Jones Jumps 3% in Stunning Post-Election Turnaround, AI Stocks Miss Out
Moomoo
·
2 hours ago
$Nasdaq Composite Index (.IXIC.US)$
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorPharmaceutical industry
Industry-
Websitebotanixpharma.com